Skip to main content
. Author manuscript; available in PMC: 2013 Jun 1.
Published in final edited form as: Nat Genet. 2012 Nov 11;44(12):1341–1348. doi: 10.1038/ng.2467

Table 1.

Meta-analysis results for psoriasis loci. For known loci, the most significant SNP within 500kb (3Mb for MHC region) of the previously published SNP is shown. rs34536443 was the most strongly associated SNP in the TYK2 region, but found to be independent of the previously published SNP (rs12720356). ‘GWAS P value’: P value from the meta-analysis of the 3 GWAS datasets. ‘Immunochip P value’: the result of the meta-analysis of the two Immunochip datasets. ‘Combined P-value’: the P-value from the meta-analysis including all 5 datasets, RAF: Risk allele frequency, ‘Notable genes’: genes most likely to have an effect on the development of psoriasis.

SNP Chr. Position (bp) GWAS P-value (meta) Immunochip p-value (meta) Combined P-value Risk/ Non-risk allele RAF (Case) RAF (Ctrls) ORa (meta) Notable genes No. of genes +/− 500kb
Known Loci
rs7552167 1 24,518,643 2.3×10−5 8.4×10−8 8.5×10−12 G/A 0.878 0.858 1.21 IL28RA 26
rs9988642 1 67,726,104 2.5×10−13 3.5×10−15 1.1×10−26 T/C 0.952 0.929 1.52 IL23R 17
rs6677595 1 152,590,187 8.1×10−15 2.7×10−20 2.1×10−33 T/C 0.689 0.640 1.26 LCE3B, LCE3D 43
rs62149416 2 61,083,506 3.4×10−10 3.2×10−9 1.8×10−17 T/C 0.671 0.635 1.17 FLJ16341, REL 9
rs17716942 2 163,260,691 4.1×10−9 1.0×10−10 3.3×10−18 T/C 0.891 0.863 1.27 KCNH7, IFIH1 7
rs27432 5 96,119,273 4.4×10−8 7.5×10−14 1.9×10−20 A/G 0.309 0.274 1.20 ERAP1 7
rs1295685 5 131,996,445 8.5×10−6 6.7×10−6 3.4×10−10 G/A 0.807 0.798 1.18 IL13, IL4 21
rs2233278 5 150,467,189 4.9×10−17 5.2×10−27 2.2×10−42 C/G 0.090 0.058 1.59 TNIP1 17
rs12188300 5 158,829,527 7.5×10−23 3.3×10−32 3.2×10−53 T/A 0.132 0.095 1.58 IL12B 5
rs4406273 6 31,266,090 5.3×10−300 3.6×10−427 4.5×10−723 A/G 0.259 0.092 4.32 HLA-B, HLA-C 56
rs33980500 6 111,913,262 4.3×10−20 7.6×10−27 4.2×10−45 T/C 0.108 0.074 1.52 TRAF3IP2 8
rs582757 6 138,197,824 2.0×10−14 3.7×10−13 2.2×10−25 C/T 0.315 0.273 1.23 TNFAIP3 5
rs1250546 10 81,032,532 5.1×10−4 3.2×10−4 6.8×10−7 A/G 0.605 0.579 1.10 ZMIZ1 9
rs645078 11 64,135,298 4.7×10−3 1.5×10−4 2.2×10−6 A/C 0.626 0.609 1.09 RPS6KA4, PRDX5 36
rs2066819 12 56,750,204 7.5×10−12 8.9×10−8 5.4×10−17 C/T 0.948 0.934 1.39 STAT2, IL23A 40
rs8016947 14 35,832,666 1.4×10−9 1.6×10−9 2.5×10−17 G/T 0.600 0.564 1.16 NFKBIA 11
rs12445568 16 31,004,812 1.2×10−6 1.8×10−11 1.2×10−16 C/T 0.403 0.368 1.16 PRSS53, FBXL19 46
rs28998802 17 26,124,908 3.6×10−6 1.7×10−11 3.3×10−16 A/G 0.170 0.145 1.22 NOS2 9
rs34536443 19 10,463,118 5.1×10−10 2.6×10−22 9.1×10−31 G/C 0.974 0.953 1.88 TYK2 42
rs1056198 20 48,556,229 6.2×10−9 1.6×10−7 1.5×10−14 C/T 0.600 0.573 1.16 RNF114 11
rs4821124 22 21,979,289 5.4×10−5 1.2×10−4 3.8×10−8 C/T 0.208 0.189 1.13 UBE2L3 16
Newly Identified Loci
rs11121129 1 8,268,095 7.3×10−5 4.6×10−5 1.7×10−8 A/G 0.308 0.287 1.13 SLC45A1, TNFRSF9 15
rs7536201 1 25,293,084 7.8×10−5 6.4×10−9 2.3×10−12 C/T 0.528 0.494 1.13 RUNX3 18
rs10865331 2 62,551,472 4.5×10−4 2.6×10−7 4.7×10−10 A/G 0.404 0.374 1.12 B3GNT2 6
rs9504361 6 577,820 5.1×10−7 4.2×10−6 2.1×10−11 A/G 0.574 0.546 1.12 EXOC2, IRF4 5
rs2451258 6 159,506,600 4.4×10−4 2.0×10−5 3.4×10−8 C/T 0.362 0.348 1.12 TAGAP 8
rs2700987 7 37,386,237 3.3×10−7 4.6×10−4 4.3×10−9 A/C 0.591 0.564 1.11 ELMO1 3
rs11795343 9 32,523,737 2.8×10−7 2.1×10−5 8.4×10−11 T/C 0.628 0.597 1.11 DDX58 7
rs10979182 9 110,817,020 2.8×10−5 1.2×10−4 2.3×10−8 A/G 0.617 0.591 1.12 KLF4 0
rs4561177 11 109,962,432 1.1×10−4 1.4×10−9 7.7×10−13 A/G 0.617 0.581 1.14 ZC3H12C 4
rs3802826 11 128,406,438 1.1×10−3 2.0×10−7 9.5×10−10 A/G 0.505 0.484 1.12 ETS1 7
rs367569 16 11,365,500 2.6×10−4 4.6×10−5 4.9×10−8 C/T 0.729 0.709 1.13 PRM3, SOCS1 14
rs963986 17 40,561,579 9.9×10−5 1.2×10−5 5.3×10−9 C/G 0.169 0.154 1.15 PTRF, STAT3, STAT5A/B 42
rs11652075 17 78,178,893 1.3×10−3 7.0×10−6 3.4×10−8 C/T 0.530 0.502 1.11 CARD14 16
rs545979 18 51,819,750 1.4×10−6 2.4×10−5 3.5×10−10 T/C 0.317 0.291 1.12 POL1, STARD6, MBD2 6
rs892085 19 10,818,092 1.2×10−7 4.5×10−11 3.0×10−17 A/G 0.593 0.558 1.17 ILF3,CARM1 37
a

The overall OR was calculated using the effective sample size-weighted approach.

HHS Vulnerability Disclosure